TL1A as a therapeutic target in inflammatory bowel disease
Georgios Kokkotis, Giorgos Bamias
Topics & Concepts
MedicineInflammatory bowel diseaseCrohn's diseaseUlcerative colitisInfliximabDiseaseUstekinumabImmunologyInternal medicineInflammatory Bowel DiseaseHelicobacter pylori-related gastroenterology studiesIL-33, ST2, and ILC Pathways